Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $40.5 Million - $56.1 Million
-275,000 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$144.9 - $165.58 $34.5 Million - $39.4 Million
-237,865 Reduced 46.38%
275,000 $40.7 Million
Q1 2018

May 15, 2018

BUY
$131.46 - $151.04 $21.7 Million - $24.9 Million
164,865 Added 47.38%
512,865 $77.5 Million
Q4 2017

Feb 14, 2018

BUY
$121.17 - $134.75 $42.2 Million - $46.9 Million
348,000
348,000 $45.1 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.